Charles River Laboratories | 贷款资金



金融业
股票价格
USD
资产
USD 7.14B
现金及等价物
USD 213.77M
销售成本
USD 722.27M
流动资产
USD 1.45B
流动负债
USD 1.12B
债务
USD 2.63B
EBIT
USD 75.82M
EBITDA
USD 258.06M
员工
18.6K
EPS每股收益
USD 2.39
股本和储备
USD 3.16B
销售毛利
USD 271.96M
债务利息支出
USD 23.78M
利息收入
USD 1.1
贷款资金
USD 2.14B
市值
USD 8.08B
净收入
USD -276.56M
营业费用
USD 918.41M
营业利润
USD 75.82M
普通股股本
USD 49.22M
PE价格收益
USD 43.58
税前利润
USD 170.03M
销售收入
USD 994.2M
销售和管理费用
USD 196.14M
股票
USD 299.1M
贸易债权人
USD 148.8M
应收帐款人
USD 1.43B


贷款资金 更改 日
Agilent USD 3.05B 300M 2025-09
Align Technology USD 0 0 2024-12
Bio-Rad Laboratories USD 1.2B 300K 2025-12
Bruker USD 1.85B 131.7M 2025-12
Cardinal Health USD 8.35B 633M 2025-12
Charles River Laboratories USD 2.14B 49.09M 2025-12
Cigna USD 30.95B 4.47B 2025-09
Concord Medical Services Hldg CNY 2.27B 199.98M 2023-06
CVS Health USD 60.5B 6M 2025-12
Danaher USD 18.42B 1.58B 2025-12
Dentsply International USD 2.02B 201M 2025-09
Elevance Health USD 30.8B 376M 2025-12
Galapagos EUR 5.76M 290K 2025-09
Hologic USD 2.5B 2.1M 2025-12
Humana USD 12.37B 238M 2025-12
Illumina USD 1.49B 496M 2025-12
Incyte USD 30.2M 5.17M 2025-12
Intrexon USD 0 198.67M 2024-06
IQVIA Holdings USD 13.88B 1.09B 2025-12
Laboratory Of America USD 5.15B 800K 2025-12
Lonza CHF 4.24B 602M 2024-12
McKesson USD 5.43B 586M 2025-12
Merck EUR 10.45B 4.15B 2025-09
Mettler Toledo International USD 2.09B 58.01M 2025-12
Novartis USD 24.24B 174M 2025-09
Pfizer USD 57.41B 93M 2025-09
Quest Diagnostics USD 5.17B 4M 2025-12
Revvity USD 2.63B 543K 2025-12
Thermo Fisher Scientific USD 35.85B 4B 2025-12
United Therapeutics USD 100M 100M 2024-06
UnitedHealth USD 72.32B 79M 2025-12
Veradigm USD 200.33M 431K 2022-09
Waters USD 1.41B 460.24M 2025-12
West Pharmaceutical Services USD 202.8M 100K 2025-12


Charles River Laboratories 贷款资金 - 当前值，历史数据，预测，统计，图表和经济日历 - Feb 2026.